An article in the online version of Gastroenterology focuses on new research comparing the T cell response to gluten in children and adults with celiac disease.
Here are five key notes:
1. More than 40 children were given a three-day oral wheat challenge, at which point their immune response was analyzed.
2. The study found that T cell recognition of wheat gluten epitopes in children with celiac disease did not differ significantly from that of adults.
3. According to study author Jason Tye-Din, PhD, this result indicates that "diagnostic tools and treatments currently being developed may be applicable in celiac disease patients of all ages."
4. ImmusanT, privately held biotechnology company, announced the publication of the article.
5. The company is the developer of the Nexvax2, a disease-modifying immunotherapy.